Third Arc Bio Inc. is a clinical-stage biotechnology company developing novel multifunctional antibodies for a range of oncology and immunology & inflammation (I&I) indications.
The company focuses on designing antibody therapeutics to address diverse tumor and immune-mediated disease mechanisms and is advancing a pipeline of clinical-stage candidates.
Leadership & Board
Current Number of Employees41
Current LinkedIn Followers3,834
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$52M
Total Amount Raised$52M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$52M
Latest Funding Amount$52M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Third Arc Bio Inc had 41 employees as of September 14, 2026. The number of employees increased by 0 (0.00%) week-over-week.
41Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Third Arc Bio Inc had 3,834 followers as of September 14, 2026. The number of followers increased by 15 (0.39%) week-over-week.
3,834Latest Followers Count
15(0.39%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.